Logo image of CS.PA

AXA SA (CS.PA) Stock Fundamental Analysis

EPA:CS - Euronext Paris - Matif - FR0000120628 - Common Stock - Currency: EUR

41.525  -0.16 (-0.4%)

Fundamental Rating

5

Overall CS gets a fundamental rating of 5 out of 10. We evaluated CS against 39 industry peers in the Insurance industry. CS has only an average score on both its financial health and profitability. CS is not valued too expensively and it also shows a decent growth rate. Finally CS also has an excellent dividend rating. With these ratings, CS could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CS was profitable.
CS had a positive operating cash flow in the past year.
In the past 5 years CS has always been profitable.
Each year in the past 5 years CS had a positive operating cash flow.
CS.PA Yearly Net Income VS EBIT VS OCF VS FCFCS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

CS's Return On Assets of 1.18% is in line compared to the rest of the industry. CS outperforms 56.41% of its industry peers.
Looking at the Return On Equity, with a value of 15.39%, CS is in the better half of the industry, outperforming 64.10% of the companies in the same industry.
The Return On Invested Capital of CS (1.33%) is comparable to the rest of the industry.
CS had an Average Return On Invested Capital over the past 3 years of 1.29%. This is in line with the industry average of 2.14%.
The last Return On Invested Capital (1.33%) for CS is above the 3 year average (1.29%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.18%
ROE 15.39%
ROIC 1.33%
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
CS.PA Yearly ROA, ROE, ROICCS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of CS (8.80%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of CS has grown nicely.
CS's Operating Margin of 12.32% is in line compared to the rest of the industry. CS outperforms 53.85% of its industry peers.
CS's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.32%
PM (TTM) 8.8%
GM N/A
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
CS.PA Yearly Profit, Operating, Gross MarginsCS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CS is destroying value.
CS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CS has less shares outstanding
The debt/assets ratio for CS is higher compared to a year ago.
CS.PA Yearly Shares OutstandingCS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CS.PA Yearly Total Debt VS Total AssetsCS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B

2.2 Solvency

CS has an Altman-Z score of 0.36. This is a bad value and indicates that CS is not financially healthy and even has some risk of bankruptcy.
With an excellent Altman-Z score value of 0.36, CS belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
The Debt to FCF ratio of CS is 2.19, which is a good value as it means it would take CS, 2.19 years of fcf income to pay off all of its debts.
CS's Debt to FCF ratio of 2.19 is fine compared to the rest of the industry. CS outperforms 74.36% of its industry peers.
A Debt/Equity ratio of 0.53 indicates that CS is somewhat dependend on debt financing.
CS's Debt to Equity ratio of 0.53 is fine compared to the rest of the industry. CS outperforms 64.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 2.19
Altman-Z 0.36
ROIC/WACC0.13
WACC10.44%
CS.PA Yearly LT Debt VS Equity VS FCFCS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

CS has a Current Ratio of 0.87. This is a bad value and indicates that CS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.87, CS belongs to the top of the industry, outperforming 87.18% of the companies in the same industry.
CS has a Quick Ratio of 0.87. This is a bad value and indicates that CS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CS (0.87) is better than 87.18% of its industry peers.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.87
CS.PA Yearly Current Assets VS Current LiabilitesCS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

4

3. Growth

3.1 Past

CS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.08%, which is quite good.
Measured over the past years, CS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.09% on average per year.
The Revenue has been growing slightly by 4.38% in the past year.
CS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.16% yearly.
EPS 1Y (TTM)12.08%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%18.49%
Revenue 1Y (TTM)4.38%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%-6.94%

3.2 Future

Based on estimates for the next years, CS will show a small growth in Earnings Per Share. The EPS will grow by 5.12% on average per year.
The Revenue is expected to grow by 7.15% on average over the next years.
EPS Next Y11.56%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
EPS Next 5Y5.12%
Revenue Next Year6.29%
Revenue Next 2Y5.45%
Revenue Next 3Y2.6%
Revenue Next 5Y7.15%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CS.PA Yearly Revenue VS EstimatesCS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B 80B 100B
CS.PA Yearly EPS VS EstimatesCS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.57 indicates a reasonable valuation of CS.
Based on the Price/Earnings ratio, CS is valued a bit cheaper than 69.23% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.41, CS is valued rather cheaply.
A Price/Forward Earnings ratio of 10.37 indicates a reasonable valuation of CS.
CS's Price/Forward Earnings ratio is in line with the industry average.
CS is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.57
Fwd PE 10.37
CS.PA Price Earnings VS Forward Price EarningsCS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

CS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CS is cheaper than 64.10% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.67
EV/EBITDA N/A
CS.PA Per share dataCS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

CS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1
PEG (5Y)0.64
EPS Next 2Y9.13%
EPS Next 3Y8.44%

7

5. Dividend

5.1 Amount

CS has a Yearly Dividend Yield of 5.16%, which is a nice return.
Compared to an average industry Dividend Yield of 4.54, CS pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.35, CS pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.16%

5.2 History

The dividend of CS is nicely growing with an annual growth rate of 8.12%!
Dividend Growth(5Y)8.12%
Div Incr Years4
Div Non Decr Years4
CS.PA Yearly Dividends per shareCS.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

CS pays out 57.97% of its income as dividend. This is a bit on the high side, but may be sustainable.
CS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP57.97%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
CS.PA Yearly Income VS Free CF VS DividendCS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B
CS.PA Dividend Payout.CS.PA Dividend Payout, showing the Payout Ratio.CS.PA Dividend Payout.PayoutRetained Earnings

AXA SA

EPA:CS (7/14/2025, 1:19:17 PM)

41.525

-0.16 (-0.4%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)03-19 2025-03-19/bmo
Earnings (Next)08-01 2025-08-01
Inst Owners33.99%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap92.00B
Analysts81.54
Price Target44.83 (7.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.16%
Yearly Dividend2.02
Dividend Growth(5Y)8.12%
DP57.97%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.25%
PT rev (3m)4.68%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.36%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)6.61%
Valuation
Industry RankSector Rank
PE 11.57
Fwd PE 10.37
P/S 1.05
P/FCF 7.67
P/OCF 7.38
P/B 1.84
P/tB 3.36
EV/EBITDA N/A
EPS(TTM)3.59
EY8.65%
EPS(NY)4.01
Fwd EY9.65%
FCF(TTM)5.41
FCFY13.03%
OCF(TTM)5.63
OCFY13.55%
SpS39.42
BVpS22.54
TBVpS12.36
PEG (NY)1
PEG (5Y)0.64
Profitability
Industry RankSector Rank
ROA 1.18%
ROE 15.39%
ROCE 1.67%
ROIC 1.33%
ROICexc 1.37%
ROICexgc 1.79%
OM 12.32%
PM (TTM) 8.8%
GM N/A
FCFM 13.73%
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
ROICexc(3y)1.34%
ROICexc(5y)1.16%
ROICexgc(3y)1.75%
ROICexgc(5y)1.48%
ROCE(3y)1.62%
ROCE(5y)1.41%
ROICexcg growth 3Y10.47%
ROICexcg growth 5Y16.55%
ROICexc growth 3Y8.69%
ROICexc growth 5Y14.36%
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 2.19
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.54%
Interest Coverage 1.72
Cash Conversion N/A
Profit Quality 156.03%
Current Ratio 0.87
Quick Ratio 0.87
Altman-Z 0.36
F-Score7
WACC10.44%
ROIC/WACC0.13
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.46%
Cap/Sales(5y)0.4%
Profit Quality(3y)104.89%
Profit Quality(5y)238.88%
High Growth Momentum
Growth
EPS 1Y (TTM)12.08%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%18.49%
EPS Next Y11.56%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
EPS Next 5Y5.12%
Revenue 1Y (TTM)4.38%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%-6.94%
Revenue Next Year6.29%
Revenue Next 2Y5.45%
Revenue Next 3Y2.6%
Revenue Next 5Y7.15%
EBIT growth 1Y18.59%
EBIT growth 3Y2.9%
EBIT growth 5Y10.41%
EBIT Next Year25.76%
EBIT Next 3Y11.02%
EBIT Next 5YN/A
FCF growth 1Y240.94%
FCF growth 3Y7.74%
FCF growth 5Y9.94%
OCF growth 1Y216.74%
OCF growth 3Y7.85%
OCF growth 5Y9.48%